InsidersTradesSigma
Total declarations
Companies
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Lim Jonathan E, Director. Insider active across 4 companies, notably Erasca, Inc.. In total, 10 disclosures have been published. Breakdown: 6 buys · 0 sell. Total volume traded: €4m. History available since 14 December 2022. The latest transaction was filed on 5 December 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Lim Jonathan E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
37,724 sharesCommon StockSEC:0001415889-25-002957:0
525,274 sharesCommon StockSEC:0000950170-24-041843:0
721,850 shares@ US$1.68728.3% of flowCommon StockSEC:0001209191-23-057681:0
Canonical exit: 4 Mar 2024 (T+90)
1,000,000 shares@ US$2.02648.4% of flowCommon StockSEC:0001209191-23-052403:0
Canonical exit: 3 Jan 2024 (T+90)
100,000 shares@ US$2.756.4% of flowCommon StockSEC:0001209191-23-035590:0
Canonical exit: 6 Sept 2023 (T+90)
100,000 shares@ US$2.846.6% of flowCommon StockSEC:0001209191-23-021458:0
Canonical exit: 26 Jun 2023 (T+90)
60,000 shares@ US$3.8575.4% of flowCommon StockSEC:0001209191-23-002802:0
Canonical exit: 10 Apr 2023 (T+90)
40,000 shares@ US$4.994.7% of flowCommon StockSEC:0001209191-22-061352:0
Canonical exit: 14 Mar 2023 (T+90)
5,135,390 sharesCommon StockSEC:0000899243-21-029085:0
72,000 sharesCommon StockSEC:0001209191-16-090805:0
10 of 10 declarations
About Lim Jonathan E
Lim Jonathan E is an Administrateur linked to Erasca, Inc., Maze Therapeutics, Inc., Boundless Bio, Inc. and Ignyta, Inc. Across 10 filings in total, the 10 sampled filings, from 2016-01-11 to 2025-02-04, concern acquisitions totaling EUR 3965104 and include no sales.
